東方鉭業(000962.SZ):生產的高純鉭粉、高純鉭錠、12英寸鉭靶坯已實現全流程技術突破和產業貫通
格隆匯7月31日丨東方鉭業(000962.SZ)在互動平台表示,公司生產的超導鈮材主要應用在低温超導領域,公司生產的鈮超導腔主要應用於高能同步輻射光源(HEPS)、加速器驅動嬗變研究裝置(CiADS)、硬X射線自由電子激光裝置(SHINE)、強流重離子加速器裝置(HIAF)等國家大科學裝置。在半導體領域,公司生產的高純鉭粉、高純鉭錠、12英寸鉭靶坯已實現全流程技術突破和產業貫通。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.